Literature DB >> 3599350

Reversal of chronic polymyositis following intravenous immune serum globulin therapy.

C M Roifman, F M Schaffer, S E Wachsmuth, G Murphy, E W Gelfand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3599350     DOI： 10.1001/jama.1987.03400040111034

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  15 in total

Review 1.  Rheumatology.

Authors:  R A Asherson; R Cervera; D P D'Cruz; G R Hughes
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

Review 2.  Current management of polymyositis and dermatomyositis.

Authors:  C V Oddis; T A Medsger
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

Review 3.  Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review.

Authors:  Dong Xue Wang; Xiao Ming Shu; Xiao Lan Tian; Fang Chen; Ning Zu; Li Ma; Guo Chun Wang
Journal:  Clin Rheumatol       Date:  2012-01-26       Impact factor: 2.980

Review 4.  [Intravenous immunoglobulins in chronic idiopathic myositis].

Authors:  H Michels; G-R Burmester; F Buttgereit
Journal:  Z Rheumatol       Date:  2005-03       Impact factor: 1.372

5.  Nervous system disease, immunological features, and HLA phenotype in Sjögren's syndrome.

Authors:  A Hietaharju; M Korpela; J Ilonen; H Frey
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

6.  Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.

Authors:  M Uchuya; F Graus; F Vega; R Reñé; J Y Delattre
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

7.  Intravenous immune globulin.

Authors:  E P Gabor
Journal:  West J Med       Date:  1995-03

Review 8.  Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.

Authors:  S C Jordan; M Toyoda
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

9.  Indications for intravenous gammaglobulin therapy in inflammatory myopathies.

Authors:  P Cherin; S Herson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

Review 10.  Use of Rescue Therapy with IVIG or Cyclophosphamide in Juvenile Myositis.

Authors:  Theonymfi Doudouliaki; Charalampia Papadopoulou; Claire T Deakin
Journal:  Curr Rheumatol Rep       Date:  2021-03-08       Impact factor: 4.592
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.